Methanolic extract and nanosilver of Feijoa sellowiana reduce Salmonella typhimurium infection in female BALB/c mice
- PMID: 40877364
- PMCID: PMC12394428
- DOI: 10.1038/s41598-025-16334-5
Methanolic extract and nanosilver of Feijoa sellowiana reduce Salmonella typhimurium infection in female BALB/c mice
Abstract
Increasing resistance to antibiotics has led to research into new treatment options. Recent studies suggest the use of plant extracts as an alternative strategy. Feijoa is widely known for its efficacy against a broad spectrum of bacterial pathogens. In this study, the antibacterial activity of methanolic extract and nanosilver of Feijoa fruit (FF-AgNPs) was investigated in BALB/c mice infected with Salmonella enterica serovar Typhimurium (SesT). The antimicrobial effect of Feijoa fruit and FF-AgNPs was evaluated by employing minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against SesT. The efficacy of the treatment in vivo was evaluated in mice by quantifying the viable population of SesT ATCC 14028 purchased from the Iranian Biological Resource Center. Both MIC and MBC results showed a strong bactericidal effect of the Feijoa fruit and its nanosilver against SesT. According to the colony count and weight measurement results of the mice, methanolic extract of Feijoa fruit and FF-AgNPs had acceptable antimicrobial efficacy. Also, none of the mice receiving these agents died, while a high mortality rate was observed in the infected group. Due to the continuous increase in microbial resistance and the importance of pathogenic bacteria in the healthcare system, there is a growing need for the use of complementary agents that possess antimicrobial properties. The findings of the current study suggest that methanolic extract of Feijoa fruit and FF-AgNPs can be considered as a beneficial antibiotic supplements due to their favorable antimicrobial effects.
Keywords: Feijoa fruit; Salmonella; Antibacterial activity; BALB/c mice; Nanosilver.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: No conflict of interest declared. Ethics approval and consent to participate: This research was approved by ethics committee of Mazandaran University of Medical Sciences, Sari, Iran, with ethical code IR.MAZUMS.REC.1400.9193.
Figures









Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Eco-friendly silver nanoparticles from garlic: a novel therapeutic approach for treating Escherichia fergusonii wound infections.Front Cell Infect Microbiol. 2025 Jun 30;15:1604507. doi: 10.3389/fcimb.2025.1604507. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40661972 Free PMC article.
-
IITR00803: a benzoxazole-nitrothiophene small molecule with broad-spectrum antibacterial potential.Microbiol Spectr. 2025 Sep 2;13(9):e0114425. doi: 10.1128/spectrum.01144-25. Epub 2025 Aug 12. Microbiol Spectr. 2025. PMID: 40792514 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
A systematic review on natural products with antimicrobial potential against WHO's priority pathogens.Eur J Med Res. 2025 Jul 1;30(1):525. doi: 10.1186/s40001-025-02717-x. Eur J Med Res. 2025. PMID: 40597250 Free PMC article.
References
-
- Hung, Y.-T., Lay, C.-J., Wang, C.-L. & Koo, M. Characteristics of nontyphoidal Salmonella gastroenteritis in Taiwanese children: A 9-year period retrospective medical record review. J. Infect. Public Health10, 518–521 (2017). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical